CAR T-cell therapy for leukemia leads to remissions in clinical trial – Fred Hutch News Service
Fred Hutch News Service |
CAR T-cell therapy for leukemia leads to remissions in clinical trial
Fred Hutch News Service “It was not known whether CAR T-cells could be used to treat these high risk CLL patients,” said lead author Dr. Cameron Turtle, an immunotherapy researcher at Fred Hutch. “Our study shows that CD19 CAR T-cells are a highly promising treatment for CLL … Promising Treatment For Leukemia Leads To Remission In Clinical … |
